A similar mechanism may operate in other solid tumors with PTHrP-mediated hypercalcemia and elevated inflammatory cytokine levels, and a trial of glucocorticoid therapy may be considered if standard treatments are ineffective. This evidence concerns the gene PTHLH and hypercalcemia disease.